The DOI matches its Crossref record.
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
Abstract
When salicylazosulfapyridine (SAS) is fed to conventional rats, none of the drug is re covered in the urine, feces or cecum; the excreta contain tile products of azo bond re duction, sulfapyridine and 5-aminosalicylate and their metabolites in yields of greater than 50%. When tile intestinal microflora of conventional rats is decreased by the admin istration of neomycin, unchanged SAS is recovered in the cecum and feces. When an oral (lose of SAS is given to germ-free rats, recoveries of tile drug in the feces are over 50% whereas the urine contains an additional 1 to 2%. None of the metabolites of SAS char acteristic of conventional rats is found in the excreta of germ-free rats. When germ-free rats are infected with four specific bacteria normally found in the intestinal tract of ro dents, SAS is metabolized as in conventional rats. Bacterial strains representative of those found in the intestinal tract of the human and the rodent were cultured in the presence of SAS and in all cases azo bond reduction was detected. These findings indicate that tile intestinal bacteria are responsible for the initial reaction in SAS transformation and raise questions concerning the amount of intact SAS that reaches the presumed site of its action in inflammatory disease of the lower intestine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intact sulfasalazine can be recovered from the stool of antibiotic-treated or germ-free rats, but not in conventionally-raised animals42.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [42]
In the citing paper
“a simplified gut microbiota composed of 4 bacterial strains (Bacteroides sp., Streptococcus faecalis, and 2 Lactobacillus sp.) is sufficient to restore sulfasalazine metabolism in gnotobiotic rats and the in vitro incubation of sulfasalazine with bacterial isolates from these animals results in drug cleavage42.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [42]
Citations
Cites
Still being checked.
Cited by
Chemical transformation of xenobiotics by the human gut microbiota
Koppel, N., Maini Rekdal, V., & Balskus, E. P. (2017) · Science · doi:10.1126/science.aag2770 · Cited by 1,080
The Impact of Food Bioactives on Health
(2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4 · Cited by 805
Brown, M. A., & De Vito, S. C. (1993) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643389309388453 · Cited by 765
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Spanogiannopoulos, P., Bess, E. N., Carmody, R. N., & Turnbaugh, P. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.17 · Cited by 717
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656
Metadata
- Authors
- PEPPERCORN, M. A., & GOLDMAN, P.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1972-06
- Volume
- 181
- Issue
- 3
- Pages
- 555-562
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2253251593
- Cited by
- 450
- References
- 0
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 16 · 2020: 27 · 2019: 20 · 2018: 12 · 2017: 8 · 2016: 15 · 2015: 10 · 2014: 13 · 2013: 6 · 2012: 8
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- sulfasalazine, intestinal bacteria, drug metabolism, azo bond reduction, sulfapyridine, neomycin, germ-free rats, urinary excretion, inflammatory bowel disease
- MeSH terms
- Animals, Bacteria, Bacteroides, Bacteroides Infections, Biotransformation, Cecum, Chromatography, Thin Layer, Feces, Germ-Free Life, Humans, Intestinal Absorption, Intestinal Mucosa, Intestines, Lactobacillus, Neomycin, Sulfasalazine, Streptococcal Infections, Streptococcus, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE. https://app.cochat.ai/papers/10.1016/s0022-3565(25)29238-2
- The paper
- PEPPERCORN, M. A., & GOLDMAN, P. (1972). THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)29238-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.